LYCOS RETRIEVER 
Proscar: Patients
built 615 days ago
Proscar should be taken indefinitely. Most patients will see an improvement in urinary flow within three to four months. The improvement may increase throughout the first 12 months. The drug should be continued to maintain the benefits.
Source:
The results of MTOPS are consistent with the findings of the 4-year, placebo-controlled study PLESS (see CLINICAL PHARMACOLOGY, Clinical Studies) in that treatment with Proscar reduces the risk of acute urinary retention and the need for BPH-related surgery. In MTOPS, the risk of developing acute urinary retention was reduced by 67% in patients treated with Proscar compared to patients treated with placebo (0.8% for Proscar and 2.4% for placebo). Also, the risk of requiring BPH-related invasive therapy was reduced by 64% in patients treated with Proscar compared to patients treated with placebo (2.0% for Proscar and 5.4% for placebo).
Source:
Proscar should not be administered on patients who are pregnant or are pregnant to any of its ingredients. In fact, there is a possibility of certain drugs interacting with Finasteride; and therefore it is important to apprise your health care professional of any kind of medications that you may be taking. A common side effect of this drug may include reduced sexual ability or desire.
Source:
In order to treat your symptoms and control your BPH effectively, it is important that you continue to take Proscar for as long as your doctor prescribes it, even if you do not feel an immediate benefit. Some patients show early improvement in symptoms, but you may need to take Proscar for at least six months to see if Proscar helps you. Proscar works best when taken long term.
Source:
Small amounts of finasteride have been recovered from the semen in subjects receiving 'Proscar' 5 mg/day. It is not known whether a male foetus may be adversely affected if his mother is exposed to the semen of a patient being treated with finasteride. Therefore, when the patient's sexual partner is or may potentially be pregnant, the patient should either avoid exposure of his partner to semen (e.g. by use of a condom) or discontinue 'Proscar'.
Source:
No clinical benefit has been demonstrated in patients with prostate cancer treated with Proscar. Patients with BPH and elevated PSA were monitored in controlled clinical studies with serial PSAs and prostate biopsies. In these BPH studies, Proscar did not appear to alter the rate of prostate cancer detection, and the overall incidence of prostate cancer was not significantly different in patients treated with Proscar or placebo.
Source:
MORE ABOUT
Patients